Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine)-2h infusion for 5 days-as first-line treatment for advanced low grade non-Hodgkin's lymphoma

Author： Fridrik M.A.   Jager G.   Kienzer H.R.   Hausmaninger H.   Oppitz P.   Krieger O.   Zabernigg A.   Lang A.   Neubauer M.   Weidinger G.   Schiller L.   Seewann H.L.   Chott A.   Linkesch W.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.10, 1998-09, pp. : 1560-1564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2-Chloro-deoxyadenosine Induces Durable Complete Remission in Castleman's Disease but may Accelerate its Transformation to Non-Hodgkin's Lymphoma

By Colleoni Gisele W. B.   Duarte Luiz Cláudio C.   Kerbauy Fábio Rodrigues   Lobão Marcos   Yunis Melissa Palis   Alves Antonio Correa   de Souza Vanda Akiko Ueda Fick   Bordin José Orlando   de Oliveira José Salvador R.  

Acta Oncologica, Vol. 42, Iss. 7, 2003-11 ,pp. : 784-787

Informa Healthcare

Access to resources Recommend Favorite

The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia

By Robak T.   Blasinska-Morawiec M.   Blonski J.Z.   Krykowski E.   Komarnicki M.   Trepinska E.   Kazmierczuk M.   Hansz J.   Dmoszynska A.   Rolinski J.   Konopka L.   Skotnicki A.B.   Nowak W.S.   Kotlarek-Haus S.   Zdziarska B.   Urasinski I.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2347-2351

Elsevier

Access to resources Recommend Favorite

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

By Xu N.   Shen P.   Zhang X.   Yu L.   Bao H.   Shi G.   Huang S.   Chen J.   Mou H.   Fang W.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy

By Lavely W.C.   Delbeke D.   Greer J.P.   Morgan D.S.   Byrne D.W.   Price R.R.   Hallahan D.E.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 307-315

Elsevier

Access to resources Recommend Favorite

Development of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma 13 years after treatment with cladribine

By Berghoff Martin  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1340-1342

Informa Healthcare

Access to resources Recommend Favorite